Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Liming Jin is active.

Publication


Featured researches published by Liming Jin.


The FASEB Journal | 2006

Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction

Liming Jin; Tongyun Liu; Gwen A. Lagoda; Hunter C. Champion; Trinity J. Bivalacqua; Arthur L. Burnett

Epidemiologic studies have shown that aging accounts significantly for the prevalence of erectile dysfunction (ED). The pathophysiology of ED during aging and its underlying molecular mechanisms are largely unknown. We hypothesized that increased RhoA/Rho‐kinase signaling is a major factor in the pathogenesis of age‐associated ED and the mechanism involves increased penile smooth muscle contractility through inhibition of myosin light chain phosphatase. Male Fischer 344 young (4 month old) and aged (20–22 month old) rats underwent erectile function testing in vivo by measuring intracavernosal pressure (ICP) and mean arterial blood pressure (MAP) upon electrical stimulation of the cavernous nerve. The data demonstrated that erectile function was significantly lower in aged rats than that in young rats at all voltages tested (P<0.05). Western blot analysis results showed that there were no significant changes in protein expressions of RhoA, Rho‐kinase‐? and ‐? isoforms, ?


Journal of Pharmacology and Experimental Therapeutics | 2006

Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats

Liming Jin; Zhekang Ying; Rob H. P. Hilgers; Jia Yin; Xueying Zhao; John D. Imig; R. Clinton Webb


The Journal of Sexual Medicine | 2008

NADPH Oxidase Activation: A Mechanism of Hypertension-Associated Erectile Dysfunction

Liming Jin; Gwen A. Lagoda; Romulo Leite; R. Clinton Webb; Arthur L. Burnett


Clinical Science | 2006

RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.

Liming Jin; Arthur L. Burnett


The Journal of Urology | 2009

Serum Biomarker Measurements of Endothelial Function and Oxidative Stress After Daily Dosing of Sildenafil in Type 2 Diabetic Men With Erectile Dysfunction

Arthur L. Burnett; Travis D. Strong; Bruce J. Trock; Liming Jin; Trinity J. Bivalacqua; Biljana Musicki

and myosin light chain phosphatase target subunit (MYPT1); however, membrane‐bound RhoA and phosphorylated MYPT1 were increased in aged rat penes by 95 ± 15 and 56 ± 8% (P<0.05), respectively, indicating enhanced RhoA and Rho‐kinase activity. Inhibition of Rho‐kinase with Y27632 maximally increased ICP/MAP to 0.72 ± 0.05 in aged rats vs. 0.47 ± 0.06 in young rats (P<0.05). Gene transfer of adeno‐associated virus (AAV) encoding dominant negative RhoA (T19NRhoA) to penes of aged and young rats for 7 days markedly improved erectile function in aged rats when compared with that in young rats (P<0.05). These observations were also supported by Rho‐kinase activity assay results showing that basal Rho‐kinase activity in aged rat penes receiving AAV vehicle treatment was twofold greater than that in young rat penes receiving AAV vehicle treatment, while it was reduced to a level similar to that in young rat penes after gene therapy of T19NRhoA (P<0.05). Taken together, these data suggest that impaired erectile function during the aging process involves increased RhoA/Rho‐kinase signaling, and this pathway may be exploited for the treatment of age‐associated ED.


Expert Opinion on Therapeutic Targets | 2006

Nitric oxide/redox-based signalling as a therapeutic target for penile disorders

Arthur L. Burnett; Biljana Musicki; Liming Jin; Trinity J. Bivalacqua

Spontaneous tone in large arteries may contribute to the pathogenesis of hypertension. Reactive oxygen species and Ca2+ influx have been shown to stimulate the development of spontaneous tone in isolated aortic rings in several models of hypertensive rats. The aim of this study was to investigate the role of the RhoA/Rho-kinase signaling pathway in the development of spontaneous tone in angiotensin II-induced hypertension and to explore the underlying mechanisms of RhoA/Rho-kinase activation. Our results showed that spontaneous tone was greatly enhanced in endothelium-denuded aortic rings from angiotensin II-induced hypertensive rats compared with their normotensive counterparts (73 ± 5 versus 7 ± 3% of phenylephrine-induced maximal contraction, respectively). The Rho-kinase inhibitor (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide (Y-27632) (0.1-10 μM) concentration dependently inhibited spontaneous tone in aortic rings from angiotensin II-treated rats. NADPH oxidase inhibitors diphenylene iodonium and apocynin also significantly reduced spontaneous tone. Chronic angiotensin II treatment markedly increased RhoA protein expression (57%) but had no effect on Rho guanine nucleotide exchange factor mRNA or Rho-kinase protein expression levels. In endothelium-denuded rings from normotensive rats, angiotensin II (100 nM) increased RhoA membrane translocation and phosphorylation of the myosin light chain phosphatase target subunit, which were both blocked by the NADPH oxidase inhibitor diphenylene iodonium (10 μM). In conclusion, these data suggest that chronic treatment with angiotensin II leads to up-regulation of the RhoA/Rho-kinase pathway, contributing to spontaneous tone development in rat aorta. Increased NADPH oxidase-dependent reactive oxygen species may be one of the mechanisms mediating the RhoA/Rho-kinase activation.


American Journal of Nephrology | 2011

Glomerular Expression of Kidney Injury Molecule-1 and Podocytopenia in Diabetic Glomerulopathy

Xueying Zhao; Yuanyuan Zhang; Lingyun Li; David R. Mann; John D. Imig; Nerimiah Emmett; Gary H. Gibbons; Liming Jin

INTRODUCTION Hypertension is a risk factor for erectile dysfunction (ED). The pathophysiologic basis of ED in hypertension remains largely unknown. AIM The goal of this study was to test the hypothesis that increased nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity contributes to the development of hypertension-associated ED. METHODS Male Sprague-Dawley rats were implanted with osmotic pumps containing saline or angiotensin II (Ang II, 70 ng/min) for 28 days and treated with or without the NADPH oxidase inhibitor apocynin (10 mM) in the drinking water. MAIN OUTCOME MEASURES Erectile function was examined by measuring the mean arterial blood pressure (MAP) and intracavernosal pressure (ICP) upon electrical stimulation of the cavernous nerve. Protein expression levels of NADPH oxidase subunits were analyzed by Western blot. Reactive oxygen species production was determined by dihydroethidium (DHE) staining and thiobarbituric acid reactive substances (TBARS) assay. RESULTS Maximum ICP (MaxICP) and ICP area under the curve, which were normalized by MAP, were significantly reduced in Ang II-infused hypertensive rats compared to that of normotensive rats (P < 0.05). Protein expression of NADPH oxidase subunit p47(phox) was significantly increased by 30% in Ang II-infused hypertensive rat penes along with increased DHE staining and TBARS levels (P < 0.05) when compared to that of controls. There were no significant changes in p67(phox) or gp91(phox) protein expression. Apocynin reduced NADPH oxidase protein expression and TBARS levels as well as improved MaxICP and ICP area under curve in Ang II-infused hypertensive rats (P < 0.05). CONCLUSIONS These data suggest that activation of NADPH oxidase is a molecular mechanism for hypertension-associated ED. Apocynin treatment exerted protective effects on erectile function through inhibition of NADPH oxidase activity, thereby reducing oxidative stress in Ang II-infused hypertensive rats. This is the first study to identify the importance of NADPH oxidase in the regulation of erectile function in vivo.


The FASEB Journal | 2006

Cytochrome P450 epoxygenases provide a novel mechanism for penile erection

Liming Jin; Clare E. Foss; Xueying Zhao; Thomas M. Mills; Mong Heng Wang; Lynnette P. McCluskey; Ganesh S.S. Yaddanapud; John R. Falck; John D. Imig; R. Clinton Webb

Penile erection is a complicated event involving the regulation of corpus cavernosal smooth muscle tone. Recently, the small monomeric G-protein RhoA and its downstream effector Rho-kinase have been proposed to be important players for mediating vasoconstriction in the penis. RhoA/Rho-kinase increases MLC (myosin light chain) phosphorylation through inhibition of MLCP (MLC phosphatase) thereby increasing Ca2+ sensitivity. This review will outline the RhoA/Rho-kinase signalling pathway, including the upstream regulators, guanine nucleotide exchange factors, GDP dissociation inhibitors and GTPase-activating proteins. We also summarize the current knowledge about the physiological roles of RhoA/Rho-kinase in both male and female erectile tissues and its aberrations contributing to erectile dysfunction in several disease states. Understanding the RhoA/Rho-kinase signalling pathway in the regulation of erection is important for the development of therapeutic interventions for erectile dysfunction.


Clinical and Experimental Pharmacology and Physiology | 2005

Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery

Cleber E. Teixeira; Liming Jin; Zhekang Ying; Trenis Palmer; Fernanda B.M. Priviero; R. Clinton Webb

PURPOSE We investigated changes in serum biomarkers of vascular function after short-term, continuous sildenafil dosing in men with type 2 diabetes with erectile dysfunction. MATERIALS AND METHODS Men with erectile dysfunction associated with type 2 diabetes mellitus were randomized to receive continuous, daily sildenafil (50 mg for 1 week run-in and 100 mg for 3 weeks) (148), or placebo (144) for 4 weeks (phase I) and then sildenafil (25, 50 or 100 mg) on demand for 12 weeks (phase II). Blood draws at baseline and after phases I and II were analyzed for cyclic guanosine monophosphate (endothelial function marker), 8-isoprostane (oxidative stress marker), and interleukin-6 and interleukin-8 (inflammatory cytokines). Primary and secondary erectile function outcome variables were affirmative responses on Sexual Encounter Profile question 3 (ability to maintain erection sufficient for sexual intercourse) and Erection Hardness Score, respectively. RESULTS Serum cyclic guanosine monophosphate levels were increased in the sildenafil group relative to the placebo group at 4 (p <0.01) and 16 (p <0.05) weeks, correlating with affirmative responses to Sexual Encounter Profile question 3 at the 4-week interval only (p <0.05). Serum 8-isoprostane levels were decreased to a nonsignificant degree in the sildenafil group at 4 weeks with no further change at 16 weeks, whereas interleukin-6 and interleukin-8 levels were unchanged at either interval, and these levels were unassociated with erectile function outcomes. CONCLUSIONS These data suggest that short-term, continuous sildenafil treatment causes systemic endothelial function to be enhanced and remain so for a duration after its discontinuation. However, they do not indicate any influence of this treatment on systemic oxidative stress or inflammation, or an effect on long-term erectile function improvement.


Expert Opinion on Therapeutic Targets | 2003

Inhibition of the tonic contraction in the treatment of erectile dysfunction.

Liming Jin; A. Elizabeth Linder; Thomas M. Mills; R. Clinton Webb

Oxidative and/or nitrosative stress is implicated in the pathogeneses of assorted penile disorders of clinical significance, notably erectile dysfunction, priapism and penile fibrosis. It is becoming increasingly recognised that the generation and activity of reactive oxygen and nitrogen species in the penis influence vascular homeostasis of this organ, with adverse effects exerted at cellular and molecular levels. Furthermore, these elements may interact with molecular signalling pathways operating in the penis, modulating their functional roles. This interaction in particular suggests that by accessing molecular targets associated with oxidative/nitrosative stress in the penis, new pharmacotherapeutic approaches may be developed to promote normal erectile ability and preserve erectile tissue health. This notion pertains to, but also extends beyond, interventions which predictably target components of the nitric oxide-based signal transduction pathway for the on-demand treatment of erectile dysfunction. The next line of pharmaceuticals for disorders of the penis, in general, may well spawn from an integrative understanding of the complex regulatory interactions influenced by, as well as influencing nitric oxide signalling in this organ.

Collaboration


Dive into the Liming Jin's collaboration.

Top Co-Authors

Avatar

R. Clinton Webb

Georgia Regents University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zhekang Ying

Georgia Regents University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gwen A. Lagoda

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Cleber E. Teixeira

State University of Campinas

View shared research outputs
Top Co-Authors

Avatar

John D. Imig

Medical College of Wisconsin

View shared research outputs
Top Co-Authors

Avatar

Trenis Palmer

Georgia Regents University

View shared research outputs
Top Co-Authors

Avatar

Xueying Zhao

Georgia Regents University

View shared research outputs
Top Co-Authors

Avatar

Tongyun Liu

Johns Hopkins University

View shared research outputs
Researchain Logo
Decentralizing Knowledge